By Allison Proffitt 

February 6, 2025 | Winners were named in the 2025 SCOPE Best of Show Awards yesterday. With more than 60 new product finalists on display on the Exhibit Hall floor and more than 300 attendees voting on their favorite new products, the Best of Show program at SCOPE highlights the very best in innovation and new technologies in clinical research.  

This year four winners were chosen by the SCOPE community—two veterans to the space and two companies new to SCOPE: Anju Software, Medidata, Biorce, and Phastar. Here are the winning new products in their own words.  

An earlier version of Anju Software’s TA Scan product has won in the past at SCOPE Europe, but the product’s new feasibility module was recognized this week in Orlando. “Our new TA Scan Feasibility Flex Module is redefining clinical trial planning by refining enrollment forecasts through a powerful blend of clinical intelligence and real-world operational data,” said Greg Fett-Davies, Senior Director of Business Development at Anju Software. “As the only solution of its kind on the market, we’re proud to lead the way in driving smarter, data-driven feasibility strategies. We are thrilled to continue innovating in the feasibility space and to have been recognized at SCOPE in both 2024 and now 2025.” 

Medidata’s recognition this year came for Clinical Data Studio. “This award is a testament to the impact that Clinical Data Studio has made in the clinical trial space,” said Olgica Klindworth, vice president, data quality and risk management solutions at Medidata. “By revolutionizing data management and driving digitalization, the platform continues to push our Data Experience portfolio forward, empowering organizations to embrace the future of clinical research.”  

Rookies of the Year  

Two of the winners this year represented a new category of award: The Rookies of the Year. These companies are new to SCOPE and their products garnered early praise from the SCOPE delegates.  

Biorce presented Jarvis V2. “Jarvis is our first and only LLM that behaves as a clinical research assistant—the only one in the world so far to be launched,” said Pedro Coelho, CEO of Biorce. The Jarvis product has over 350 live users already, and Coelho reported record high use levels.  

Finally, Phastar was honored for their Clinical Intelligence Data Analytics Platform. “Clinical trial sponsors face increasing challenges in managing vast amounts of operational, clinical, and safety data,” said Ping-Chung Chang, Business Transformation & China GM at Phastar. “Our goal has always been to provide the tools needed to simplify data aggregation, automate processes, and enable real-time insights that drive smarter decision-making. By enhancing risk-based monitoring, streamlining data analysis, and improving recruitment forecasting, we help sponsors run trials more efficiently and effectively.” 

Winning Product Descriptions 

All of the products were on display during SCOPE, but if you missed them, please see their entry descriptions below, in alphabetical order by company.  

Anju Software | TA Scan v1.7.8.3 | Booth 1016  https://www.anjusoftware.com/ta-scan-data-science/   

Brief Product Description & Technical Specifications. Be sure to specify what is new in this release:  

TA Scan is a cloud-based clinical and commercial business intelligence tool that aggregates and connects a broad range of global clinically relevant data sources. Clinical trials, presentations, publications, and many other data sources from the public domain are semantically linked into a single intuitive database. Our high-quality data and built-in advanced analytics provide an accurate, comprehensive view of global R&D activity, allowing users to make more informed decisions around their study designs, feasibility, site identification, investigator/KOL identification, and management strategies. In the past year, TA Scan expanded its core feature for clinical operations teams. TA Scan’s new Trial Feasibility Flex simplifies the highly complex process of clinical trial feasibility, thereby adding strategic and operational value. While keeping TA Scan’s high-quality data and powerful functionalities, the Trial Feasibility Flex allows more customizable manual inputs, enabling highly precise enrollment projections tailored to the users’ trial design. Through the simulation, users can assess the impact of a wide range of variables – such as country selection, preferred site lists, country-level patient distribution, regulatory delay, anticipated recruitment rate, and other trial parameters – on clinical outcomes. On top of predictive enrollment scenarios, country-level trial timings, and competitive insights, Trial Feasibility Flex provides feedback on sponsors’ preferred site list, by assessing specific trial criteria and sites’ capacity in the current competitive landscape. Moreover, it provides alternative sites with capacity to recruit. The insights generated help match reality with expectation and generate the actionable insights needed to optimize country and site selection, supporting confident and efficient trial planning.  

Biorce | Jarvis V2 | Booth 541  https://www.biorce.com/home  

Brief Product Description & Technical Specifications: 

Product Description Jarvis is the first Clinical Trial AI Assistant designed to revolutionize the planning, execution, and optimization of clinical studies. By leveraging a vast database of over 500,000 studies, Jarvis offers intelligent solutions for protocol design, feasibility analysis, site selection, and patient recruitment. Its advanced AI capabilities streamline inclusion/exclusion criteria, sample size optimization, and dosage prediction, minimizing the costly and time-intensive protocol amendments that affect 57% of trials. Jarvis empowers users with actionable insights by consolidating and analyzing data at unprecedented speed, performing hundreds of hours of research in seconds. Its intuitive interface facilitates dynamic interactions, such as providing demographic and population insights, intervention comparisons, endpoint measures, and efficacy results. Whether it’s doctors seeking patient-trial matches, researchers analyzing past methodologies, or industry stakeholders optimizing study designs, Jarvis enhances efficiency, reduces errors, and accelerates timelines. It also empowers patients by simplifying access to relevant clinical trials, reducing their burden, and expanding participation opportunities. Technical Specifications • AI Capabilities: Advanced search, trend identification, and comparative analysis across extensive clinical trial databases. • Optimization Tools: Algorithms for refining inclusion/exclusion criteria, sample size, and drug dosage predictions. • Feasibility Analysis: Site workload assessments and patient availability predictions to aid in site selection. • Data Insights: Provides patient demographics, intervention details, outcome measures, and efficacy results. • Integration: Ability to integrate with existing clinical research workflows to improve decision-making efficiency. • Time Savings: Condenses 100+ hours of research into seconds for rapid protocol development  

Medidata | Medidata Clinical Data Studio | Booth 903  https://www.medidata.com/en/clinical-data-studio/  

Brief Product Description & Technical Specifications:  

Clinical Data Studio, launched in June 2024, is a data source agnostic experience that orchestrates data integration, standardization, reconciliation, and quality management across multiple sources. Designed to simplify the complex data lifecycle by connecting numerous data sources with a streamlined data ingestion and standardization engine, Clinical Data Studio accelerates activities for clinical data management and operations teams by integrating data review and risk management capabilities in a consistent, collaborative user experience. Clinical data managers/scientists, programmers, central monitors, and medical monitors work together on all data in one experience, powered by automation, analytics, and AI, to accelerate data review workflows, mitigate data quality risks, and help ensure patient safety. This solution combines advanced capabilities for data review, medical/safety monitoring, risk management, audit trail review, and centralized statistical monitoring with a no/low-code experience for ingesting, validating, standardizing, and integrating/transforming data from multiple sources. Clinical Data Studio has a positive impact on data quality through powerful capabilities simplified in an intuitive experience: - Streamlined self-service data ingestion agnostic of source - Automated, real-time data review, reconciliation, and surveillance - Risk management and central monitoring - Self-serve dynamic visualizations for real-time safety monitoring - Bulk query management and external data vendor communication connection - Embedded AI and ML capabilities, including anomaly detection, data reconciliation, and data transformation - Flexible Clean Patient Tracker for an ongoing task and data cleanliness progress tracking - Transformation engine for low code data standardization and SDTM dataset creation - Automated mining of audit trail data with generative AI to save time and effort  

Phastar | Clinical Intelligence (Data Analytics Platform) Platform | Booth 329  https://phastar.com/solutions/digital-acceleration/  

Brief Product Description & Technical Specifications:  

The Clinical Intelligence Portal leverages data visualization and analytics to provide near real-time data access. The portal automates data processes and ensures regulatory compliance, offering user-friendly tools for deep data understanding and rapid anomaly resolution. Clinical Intelligence offers a modular approach giving clients the flexibility to select the apps that suit their specific needs and budget, or to acquire the full suite to fully optimize clinical trial processes. Whether clients require tools for visualization, analytics, data management, recruitment forecasting, RBQM, medical monitoring, DMC or more, they can adapt the platform to meet their unique requirements. A new addition to the platform is an RBQM app. The tool supports critical RBQM processes like Risk Assessment, Central Monitoring, Issue Management, Risk Reassessment, Targeted Site Monitoring, and KRI Tracking, while ensuring regulatory compliance and enabling continuous, data-driven improvements throughout the clinical trial. A key feature of RBQM applications is the ability to assign risk scores to different clinical sites or activities based on predefined criteria. These risk scores help prioritize sites that need more attention. Another notable addition is the Recruitment Forecasting app, developed in partnership with Sponsor X to address recruitment challenges. Using advanced statistical modeling, including a Kaplan-Meier model, the app predicts participant progression and treatment administration timelines, accounting for late site openings and real-time data updates. The app allowed Sponsor X to optimize site performance, based on screening duration probabilities, reducing timelines by three weeks and generating significant savings.